Proton pump inhibitors: potential cost reductions by applying prescribing guidelines

"There are opportunities for substantial cost savings in relation to proton pump inhibitors prescribing if implementation of clinical guidelines in terms of generic substitution and step-down therapy is implemented on a national basis."

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
C Cahir, T Fahey, L Tilson, C Teljeur, K Bennett
BMC Health Services Research, 2012, 12:408

Read more here.

Use of NICE appraised medicines in the NHS in England

"As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England."

Use of NICE appraised medicines in the NHS in England – 2010 and 2011, experimental statistics
The Information Centre for Health and Social Care
October 2012

Access relevant documents here.